W.L. Gore gets expanded FDA approval for endovascular graft

01/17/2012 | HealthDay News

The FDA has granted approval to W.L. Gore and Associates to expand the use of its Gore Tag Thoracic Endoprosthesis device, an endovascular graft initially approved for aneurysm treatment. The expanded label allows the use of the device for treating patients with aortic tears.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC